Roy J. and Lucille A. Carver College of Medicine, University of Iowa
Iowa City, Iowa, 52242, United States
NCT Number: NCT00055393
This study will determine whether the drug bupropion is an effective treatment for Pathological Gambling.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Iowa City, Iowa, 52242, United States
As gambling opportunities proliferate, PG has become a major health concern. Despite its importance, few treatment options with proven efficacy exist. This study will attempt to identify an effective treatment for PG.
Participants are randomly assigned to receive either bupropion or placebo for 12 weeks. Participants are assessed at baseline and at Weeks 2, 3, 4, 5, 6, 8, 10, and 12. Self administered questionnaires and interviews are used to assess participants. Follow-up assessments are made 1, 3, and 6 months after study completion.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
18 subjects in this randomly controlled double blind study received bupropion.
21 subjects received Placebo.
University of Iowa
Other
Bupropion Versus Placebo in the Treatment of Pathological Gambling
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02337634
Behavior, Disruptive, Impulse Control, and Conduct Disorders
Chicago, Illinois, United States
View Trial DetailsNCT01528982
Behavior, Disruptive, Impulse Control, and Conduct Disorders
Chicago, Illinois, United States
View Trial DetailsNCT01215357
Behavior, Disruptive, Impulse Control, and Conduct Disorders
Los Angeles, California, United States
View Trial DetailsNCT05506384
Behavior, Behavior, Addictive
Lund, Sweden
View Trial Details